Wells Fargo & Company Eyenovia, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EYEN
# of Institutions
54Shares Held
13.4MCall Options Held
13.1KPut Options Held
21.3K-
Armistice Capital, LLC New York, NY8.53MShares$768,0910.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$169,3160.0% of portfolio
-
Geode Capital Management, LLC Boston, MA558KShares$50,2190.0% of portfolio
-
Lasry Marc New York, NY548KShares$49,3020.74% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$34,9300.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $3.08M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...